Intima-media thickness of common carotid as cardiovascular risk factor in rheumatoid arthritis and metabolic

S Coaccioli1, G Capitò, M Valentini

  • 1Department of Internal Medicine, School of Medicine Perugia University, 06100 Perugia. scoaccioli@tin.it

La Clinica Terapeutica
|February 13, 2008
PubMed

Insights

Rheumatoid arthritis patients show increased intima-media thickness, indicating a significant cardiovascular risk independent of disease activity or lipid levels. This highlights rheumatoid arthritis as an independent atherosclerosis risk factor.

Area of Science:

  • Vascular Biology
  • Cardiovascular Medicine
  • Rheumatology

Background:

  • Cardiovascular disease is a major concern in inflammatory and metabolic disorders.
  • Intima-media thickness (IMT) and lipid profiles are key indicators of atherosclerosis.
  • Understanding these markers in rheumatoid arthritis (RA), type 1 diabetes mellitus (T1DM), and obesity is crucial for risk assessment.

Purpose of the Study:

  • To compare intima-media thickness (IMT) and lipid profiles in patients with RA, T1DM, and obesity against normal subjects.
  • To determine the relationship between cardiovascular risks and pro-atherosclerosis conditions in these patient groups.
  • To identify independent risk factors for atherosclerosis.

Main Methods:

  • A study involving 147 subjects, including 38 RA patients, 42 T1DM patients, 37 obese patients, and 30 normal controls.
  • Measurement of intima-media thickness (IMT) and atherosclerotic plaques using ultrasound, following established guidelines.
  • Analysis of lipid profiles in all participant groups.

Main Results:

  • Patients with rheumatoid arthritis (RA) exhibited a thickened intima-media complex.
  • This atherosclerotic risk factor in RA patients was present irrespective of disease activity or serum lipid levels.
  • The study observed varying degrees of IMT and plaque presence across RA, T1DM, and obesity groups compared to controls.

Conclusions:

  • Rheumatoid arthritis (RA) itself appears to be a significant and independent risk factor for atherosclerosis.
  • The increased atherosclerosis risk in RA patients does not seem to correlate with their lipid profile.
  • Further research is warranted to elucidate the mechanisms linking chronic inflammation in RA to cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...